Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic Syndromes × tocilizumab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 6 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Immune-related Adverse Events 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

venetoclax 27 Azacitidine 25 fludarabine 22 Cyclophosphamide 15 fludarabine phosphate 14 Decitabine 13 Specimen Handling 12 Cytarabine 12 Whole-Body Irradiation 11 Busulfan 11 Biopsy 11 Stem Cell Transplantation 10 Tacrolimus 9 Mycophenolic Acid 9 decitabine and cedazuridine drug combination 8 Granulocyte Colony-Stimulating Factor 8 Methotrexate 7 Melphalan 7 Injections 7 Thiotepa 6 Peripheral Blood Stem Cell Transplantation 5 Idarubicin 5 Filgrastim 5 Daunorubicin 5 Blood Specimen Collection 5 Mesna 4 Cyclosporine 4 Cladribine 4 thymoglobulin 3 olutasidenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡